Fas-mediated inhibition of CD4+ T cell priming results in dominance of type 1 CD8+ T cells in the immune response to the contact sensitizer trinitrophenyl

Journal of Immunology

Volumn 173, Issue 5, 2004, Pages 3178-3185

  Martin, Stefan F ^a   Dudda, Jan C ^a   Delattre, Virginie ^a   Bachtanian, Eva ^a   Leicht, Cornelia ^a   Burger, Beate ^a   Weltzien, Hans Ulrich ^b   Simon, Jan C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; GRANZYME A; GRANZYME B; HAPTEN; PERFORIN; TRINITROPHENYL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL ADHESION; CONTACT ALLERGY; CONTROLLED STUDY; EFFECTOR CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 4344659864     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.5.3178     Document Type: Article

References (50)

1. + T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur. J. Immunol. 25:3006.
2. + T cells. J. Exp. Med. 183:1001.
3. Bouloc, A., A. Cavani, and S. I. Katz. 1998. Contact hypersensitivity in MHC class II-deficient mice depends on CD8 T lymphocytes primed by immunostimulating Langerhans cells. J. Invest. Dermatol. 111:44.
4. + T cells are the dominant effector cells in trinitrophenyl- specific contact hypersensitivity. J. Invest. Dermatol. 115:260.
5. + Tc1 cells is associated with the murine immune response to the contact sensitizer trinitrophenyl. Exp. Dermatol. 12:78.
6. + T cell subsets against keratinocytes. J. Immunol. 165:3058.
7. Trautmann, A., M. Akdis, D. Kleemann, F. Altznauer, H. U. Simon, T. Graeve, M. Noll, E. B. Brocker, K. Blaser, and C. A. Akdis. 2000. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J. Clin. Invest. 106:25.
8. + T cytotoxic 1 cells inducing keratinocyte apoptosis. J. Immunol. 168:3079.
9. + T cell-mediated contact hypersensitivity. J. Exp. Med. 189:779.
10. + T cells. J. Invest. Dermatol. 111:621.
11. + T-cell clones from the peripheral blood of patients with cutaneous reactions to β-lactam antibiotics. Br. J. Dermatol. 128:619.
12. + T lymphocytes in bullous cutaneous reactions caused by β-lactam antibiotics. J. Invest. Dermatol. 101:794.
13. + T cell-mediated delayed hypersensitivity: implications for allergies, asthma, and autoimmunity. J. Allergy Clin. Immunol. 103:192.
14. Martin, S. 1993. The structural analysis of TNP-peptide epitopes for T cells. PhD thesis, University of Freiburg, Freiburg, Germany.
15. Kohler, J., S. Martin, U. Pflugfelder, H. Ruh, J. Vollmer, and H. U. Weltzien. 1995. Cross-reactive trinitrophenylated peptides as antigens for class II major histocompatibility complex-restricted T cells and inducers of contact sensitivity in mice: limited T cell receptor repertoire. Eur. J. Immunol. 25:92.
16. Kohler, J., U. Hartmann, R. Grimm, U. Pflugfelder, and H. U. Weltzien. 1997. Carrier-independent hapten recognition and promiscuous MHC restriction by CD4 T cells induced by trinitrophenylated peptides. J. Immunol. 158:591.
17. Martin, S., G. Niedermann, C. Leipner, K. Eichmann, and H. U. Weltzien. 1993. Intracellular processing of hapten-modified proteins for MHC class I presentation: cytoplasmic delivery by pH-sensitive liposomes. Immunol. Lett. 37:97.
18. Martin, S. F. 2004. T-lymphocyte mediated immune responses to chemical haptens and metal ions: implications for allergic and autoimmune disease. Int. Arch. Allergy Immunol. 134:186.
19. Martin, S., and J. C. Simon. 2001. Effector T cells and regulatory T cells in allergic contact dermatitis. Allergy Clin. Immunol. Intern. 13:117.
20. Weltzien, H. U., and E. Padovan. 1998. Molecular features of penicillin allergy. J. Invest. Dermatol. 110:203.
21. Trautmann, A., M. Akdis, E. Brocker, K. Blaser, and C. A. Akdis. 2001. New insights into the role of T cells in atopic dermatitis and allergic contact dermatitis. Trends Immunol. 22:530.
22. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
23. Adachi, M., S. Suematsu, T. Kondo, J. Ogasawara, T. Tanaka, N. Yoshida, and S. Nagata. 1995. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat. Genet. 11:294.
24. Heusel, J. W., R. L. Wesselschmidt, S. Shresta, J. H. Russell, and T. J. Ley. 1994. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977.
25. Simon, M. M., M. Hausmann, T. Tran, K. Ebnet, J. Tschopp, R. ThaHla, and A. Mullbacher. 1997. In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A × B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells. J. Exp. Med. 186:1781.
26. Simon, M. M., P. Waring, M. Lobigs, A. Nil, T. Tran, R. T. Hla, S. Chin, and A. Mullbacher. 2000. Cytotoxic T cells specifically induce Fas on target cells, thereby facilitating exocytosis-independent induction of apoptosis. J. Immunol. 165:3663.
27. Lappin, M. B., J. M. Weiss, V. Delattre, B. Mai, H. Dittmar, C. Maier, K. Manke, S. Grabbe, S. Martin, and J. C. Simon. 1999. Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection. Immunology 98:181.
28. + T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell homing subsets. J. Immunol. 172:857.
29. Russell, J. H., and T. J. Ley. 2002. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20:323.
30. Yawalkar, N., and W. J. Pichler. 2001. Immunohistology of drug-induced exanthema: clues to pathogenesis. Curr. Opin. Allergy Clin. Immunol. 1:299.
31. Yawalkar, N., F. Egli, Y. Hari, H. Nievergelt, L. R. Braathen, and W. J. Pichler. 2000. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin. Exp. Allergy 30:847.
32. Yawalkar, N., S. Schmid, L. R. Braathen, and W. J. Pichler. 2001. Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis. Br. J. Dermatol. 144:1133.
33. Ebnet, K., M. Hausmann, F. Lehmann-Grube, A. Mullbacher, M. Kopf, M. Lamers, and M. M. Simon. 1995. Granzyme A-deficient mice retain potent cell-mediated cytotoxicity. EMBO J. 14:4230.
34. + T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J. Immunol. 144:4121.
35. + T-helper and a T-killer cell. Nature 393:474.
36. Duke, R. C. 1989. Self-recognition by T cells. I. Bystander killing of target cells bearing syngeneic MHC antigens. J. Exp. Med. 5:17.
37. Dick, T., M. S. Staege, G. Reichmann, and A. B. Reske-Kunz. 1993. Manifestation of the MHC-unrestricted killing potential of a cytotoxic T cell clone requires activation in response to MHC-restricted self-presentation of antigen. J. Immunol. 150:2575.
38. + T helper 1 effectors. J. Immunol. 157:2961.
39. Berg, D. J., M. W. Leach, R. Kuhn, K. Rajewsky, W. Muller, N. J. Davidson, and D. Rennick. 1995. Interleukin 10 but not interleukin 4 is a ntural suppressant of cutaneous inflammatory responses. J. Exp. Med. 182:99.
40. Asada, H., J. Linton, and S. I. Katz. 1997. Cytokine gene expression during the elicitation phase of contact sensitivity: regulation by endogenous IL-4. J. Invest. Dermatol. 108:406.
41. + T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J. Invest. Dermatol. 114:295.
42. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389.
43. + T cells. J. Immunol. 158:4721.
44. Suzuki, I., and P. J. Fink. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187:123.
45. + T cells. Proc. Natl. Acad. Sci. USA 97:1707.
46. + T cells. J. Immunol. 165:5537.
47. Akdis, M., A. Trautmann, S. Klunker, I. Daigle, U. C. Kucuksezer, W. Deglmann, R. Disch, K. Blaser, and C. A. Akdis. 2003. T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J. 17:1026.
48. + T cells in a model for multiple sclerosis. J. Exp. Med. 194:669.
49. + T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166:7579.
50. Liblau, R. S., F.S. Wong, L. T. Mars, and P. Santamaria. 2002. Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity 17:1.